[논문]Anti-Inflammatory Effect of Cyclosporin A on Human Skin Mast Cells - 과학기술 지식인프라 ScienceON ....

참고문헌 (48) ; Lancet Calne 11 1323 1978 10.1016/S0140-6736(78)91970-0 Cyclosporin A in patients receiving renal allografts from cadaver donors ; Lancet Nussenblatt 11 235 1983 10.1016/S0140-6736(83)90230-1 Treatment of intraocular inflammatory diseases with cyclosporin A ; Arthritis Rheum Weinblatt 30 11 1987 10.1002/art.1780300102 Cyclosporin A treatment of refractory rheumatoid arthritis ; N Engl J Med Brynskow 321 845 1989 10.1056/NEJM198909283211301 A placebo-controlled, double-blind, randomized trial of cyclosporine therapy in active chronic Crohn's disease

[논문]On the nature of sarcoidosis - 과학기술 지식인프라 ScienceON (사이언스온)

On the nature of sarcoidosis European journal of internal medicine, v.23 no.2, 2012년, pp.105 - 109 내보내기 MyON담기 인용 한글로보기 Abstract ▼ AI-Helper AbstractMore than...

[논문]Anti-Inflammatory Effect of FK-506 on Human Skin Mast Cells - 과학기술 지식인프라 ScienceON (사이언....

Clin Immunol Immunopathol Marone 50 24 1989 10.1016/0090-1229(89)90111-6 Pathophysiology of human basophils and mast cells in allergic disorders ; J Immunol Seder 147 903 1991 10.4049/jimmunol.147.3.903 Purified Fce R+ bone marrow and splenic non-B, non-T cells are highly enriched in the capacity to produce IL-4 in response to immobilized IgE, IgG2a, or ionomycin ; Acta Derm Venereol Wiesner-Menzel 61 465 1981 Electron microscopical evidence for a direct contact between nerve fibres and mast cel ...

AU2022369312A1 - Heterodimeric fc cytokines and uses thereof

Description ; HETERODIMERIC FC CYTOKINES AND USES THEREOF ; CROSS-REFERENCE TO RELATED PATENT APPLICATIONS ; The present application claims benefit of priority to U.S. Provisional Patent Application No. 63/257,913, filed October 20, 2021, which is incorporated by reference for all purposes. ; BACKGROUND OF THE INVENTION

US20130072470A1 - Novel tricyclic compounds

Info ; Patent citations (4) · Cited by (22) · Legal eventsSimilar documentsPriority and Related Applications · USPTO · USPTO PatentCenterUSPTO AssignmentEspacenet · Global Dossier · Discuss

(12) United States Patent

(12) United States Patent Bancel et al. USOO9587003B2 US 9,587,003 B2 (10) Patent No.: (45) Date of Patent: Mar. 7, 2017 (54) MODIFIED POLYNUCLEOTIDES FOR THE PRODUCTION OF ONCOLOGY RELATED...

US10300042B2 - Apremilast for the treatment of a liver disease or a liver function abnormality

Worldwide applications ; 2015-06-22 · Application filed by Celgene Corp ; 2015-06-22 · Priority to US15/321,718 ; 2017-05-25 · Publication of US20170143671A1 ; 2017-11-17 · Assigned to CELGENE CORPORATION

WO2013043826A1 - Tricyclic compounds useful as protein kinase inhibitors

Abstract : The invention provides compounds of Formula (I), pharmaceutically acceptable salts, pro-drugs, biologically active metabolites, stereoisomers and isomers thereof wherein the variable are defined herein. The compounds of the invention are useful for treating immunological and oncological conditions. Classifications : C07D487/14 Ortho-condensed systems · View 7 more classifications

US10610516B2 - Methods of using (+)- 2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylamino....

Worldwide applications ; 2004 IL · 2005 US · 2007 · 2008 · 2009 CYUSJP · 2010 IL · 2012 · 2016 · 2018 · 2019 CYLUBEHUCYNLFRCY · 2020

What commercials are we hating? Part 2 - /threads

What commercials are we hating? Part 2 ; Mountain America Credit Union is running ads almost non stop with the some screech voiced hag who calls herself the Food Nanny. She looks and sounds like a moron. ; Please fill the original thread before posting here.